Aspect Biosystems

Eric Roos, Chief Business Development Officer

Oct. 14 | 11:00am | BlueRock Therapeutics Ballroom

Vancouver, Canada
(Private)

In-person Presentation
Aspect Biosystems is a biotechnology company creating bioprinted therapeutics as medicines of the future. Aspect is applying its microfluidic 3D bioprinting technology internally to develop these advanced cell therapies, and partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
www.aspectbiosystems.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions